Fake Avastin in the U.S.: A counterfeit version of Roche’s Avastin anti-cancer drug has been found in the U.S., though it’s not known how much was distributed, whether patients received it or whether it caused harm, the WSJ reports . The FDA has notified 19 medical practices in the U.S. that it says might have purchased the fake Avastin, which doesn’t contain the active ingredient in the real drug. A spokeswoman for Roche unit Genentech says the counterfeit drugs were labeled in French, identified Roche instead of Genentech as the manufacturer and had lot numbers starting with B86017, B6011 or B6010. “Doc Fix” Deal Coming?: Lawmakers have reached a tentative agreement that would extend the Medicare “doc fix” for ten months, putting off a scheduled reimbursement cut, Dow Jones Newswires reports . The extension is part of a broader agreement that would also extend the payroll tax cut and jobless benefits; the “doc fix” would be paid for with spending reductions, DJN says. Doctors Firing Patients: More pediatricians
Originally posted here:
A.M. Vitals: FDA Warns of Fake Avastin in U.S.


John


